Theravance Biopharma's New Research on Ampreloxetine at AAN 2025 Highlights Drug's Potential for Neurogenic Orthostatic Hypotension #Ireland #Dublin #Theravance_Biopharma #Ampreloxetine #Neurogenic_Orthostatic
0
0
0
0
Theravance Biopharma's New Research on Ampreloxetine at AAN 2025 Highlights Drug's Potential for Neurogenic Orthostatic Hypotension #Ireland #Dublin #Theravance_Biopharma #Ampreloxetine #Neurogenic_Orthostatic